Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
T. Verheij (Utrecht, Netherlands). Antibiotic use and misuse in the community: how to manage the problem. Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections

Member's Comments

No comment yet.

Related content which might interest you: Improving outcome in elderly patients with pneumonia Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI Year: 2005 Quality-indicators and prognostics in CAP in three populations Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches Year: 2005 Developing outcome-based guidelines in CAP and AECB Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI Year: 2005 Relevance of correct antibiotic choice in community-acquired pneumonia (CAP) Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches Year: 2005 Detecting problems of patients with asthma: a community problem with a community approach Source: Annual Congress 2006 - Connecting with the community: collaborations that work Year: 2006 Cost-effective antibiotic management of community acquired pneumonia Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=198 Year: 2004 Community-acquired pneumonia as an emergency: time for an aggressive intervention to lower mortality Source: Eur Respir J 2011; 38: 253-260 Year: 2011 Pattern of antibiotic resistance in hospital acquired pneumonia in a country where antibiotics are available over the counter without doctors prescription Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 Can CAP guideline adherence improve patient outcome in internal medicine departments? Source: Eur Respir J 2008; 32: 902-910 Year: 2008 The APO-audit in the primary health care of archangelsk region: the way to the effective therapy of community-acquired respiratory infections Source: Annual Congress 2009 - Diagnostic strategies in primary respiratory care Year: 2009 Epidemiology, antimicrobial resistance and clinical outcomes in nursing home associated pneumonia compared to community acquired pneumonia Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 Guideline-concordant therapy and outcomes in healthcare-associated pneumonia Source: Eur Respir J 2011; 38: 878-887 Year: 2011 Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens Source: Eur Respir J 2002; 20: 432-439 Year: 2002 Multidisciplinary interventions to improve narrow spectrum antibiotic use in pediatric community acquired pneumonia Source: International Congress 2016 – Paediatric respiratory infection Year: 2016 Determinants of performance of indicators on antibiotic use in community-acquired pneumonia (CAP) at hospitals Source: Eur Respir J 2005; 26: Suppl. 49, 638s Year: 2005 Defining stability in pneumonia and the non-responding pneumonia Source: Annual Congress 2005 - Outcome in severe pneumonia Year: 2005 Effectiveness of the empirical administration of antibiotics in community acquired pneumonia (CAP) Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007 Epidemiological impact of antibiotic use/misuse in the community Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=165 Year: 2004 Antibiotic therapy of community-acquired pneumonia in the hospital setting: national guidelines and real clinical practice. Source: International Congress 2017 – COPD management Year: 2017 Actual problem in childhood - community acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 167s Year: 2005